• Signaling Molecule causes Regression of Blood Vessels

    Immunotherapy with T-cells offers great hope to people suffering from cancer. The signaling molecule interferon gamma, which is produced by T-cells, plays a key role in the therapy.

    Read press release

  • Research 4.0: Berlin Institute of Health moves to electronic lab notebooks

    Starting in April 2017, the QUEST – Center for Transforming Biomedical Research at BIH will begin to implement electronic lab notebooks to manage research data.

    Read more

  • Cutting costs with more flexible trial designs

    Ulrich Dirnagl from QUEST – Center for Transforming Biomedical Research of the BIH and the Charité has shown that different preclinical trial designs can increase efficiency and deliver more powerful results.

    An interview with Ulrich Dirnagl

  • Einstein Center Digital Future inaugurated

    Berlin becomes the hotspot of digital research

    Read more

  • Sanofi is looking for collaborations in immunology

    Sanofi is looking for potential collaboration partners at BIH, Charité and MDC to drive forward exciting projects and collaboration activities in the field of immunology.

    More information about the call

Paper of the Month 'January'

Paper of the Month 'January'

Angela M. Kaindl of the Charité Institute of Cell Biology and Neurobiology was awarded with the Paper of the Month for her publication on the CDK5RAP2 gene in germ cell development.

New Junior Group Leader

New Junior Group Leader

Since March 1, 2017, Martin Kircher has joined the BIH as a second junior group leader for bioinformatics. In a brief portrait he describes his research and experiences.

Newsfeed